If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Mounjaro™ (tirzepatide) injection
2.5 mg/5 mg/7.5 mg/10 mg/12.5 mg/15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Can tirzepatide be used in people with autoimmune abnormalities such as lupus or rheumatoid arthritis?
Tirzepatide has not been studied in people with autoimmune abnormalities.
See important safety information, including boxed warning, in the attached prescribing information.
No information is available on the use of tirzepatide in patients with significant and active autoimmune abnormalities such as lupus or rheumatoid arthritis. Participants were excluded from clinical trials if they were receiving or were likely to require systemic glucocorticoids during the course of the study.
Enclosed Prescribing Information
Date of Last Review: April 26, 2022